| ADCCX | CGFAX | ADCCX / CGFAX | |
| Total Expense Ratio | 1.91 | 0.62 | 308% |
| Annual Report Gross Expense Ratio | 2.00 | 0.62 | 323% |
| Fund Existence | 19 years | 24 years | - |
| Gain YTD | 1.632 | 7.542 | 22% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 443M | 361B | 0% |
| Annual Yield % from dividends | 0.00 | 0.23 | - |
| Returns for 1 year | -6.79 | 4.35 | -156% |
| Returns for 3 years | -8.79 | 43.61 | -20% |
| Returns for 5 years | -32.51 | 15.48 | -210% |
| Returns for 10 years | -10.30 | 110.12 | -9% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VLACX | 138.73 | N/A | N/A |
| Vanguard Large Cap Index Investor | |||
| BDBPX | 31.82 | N/A | N/A |
| iShares Russell 2000 Small-Cap Idx Inv P | |||
| MDDAX | 9.43 | N/A | N/A |
| MassMutual Diversified Value A | |||
| GTMRX | 19.22 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Growth R | |||
| MCYAX | 16.47 | -0.01 | -0.06% |
| NYLI Candriam Emerging Markets Eq Cl A | |||